Crescent Grove Advisors, LLC Oncolytics Biotech Inc Transaction History

Crescent Grove Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 24, 2022	SELL	$1.39 - $2.3 $13,899 - $23,000	-10,000 Closed	0 $0
Q2 2020 Aug 03, 2020	SELL	$1.33 - $2.76 $1,050 - $2,180	-790 Reduced 7.32%	10,000 $19,000
Q4 2019 Feb 03, 2020	BUY	$0.42 - $4.76 $4,531 - $51,360	10,790 New	10,790 $51,000

1.32M

Ticker ONCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,867,400
Market Cap $68.3M
Description
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...

Get notified when there are updates to the investment portfolio of Crescent Grove Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Crescent Grove Advisors, LLC with notifications on news.